Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Assets Average (2021 - 2025)

Historic Assets Average for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q3 2025 value amounting to $13.5 million.

  • Rani Therapeutics Holdings' Assets Average fell 6901.77% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year decrease of 6901.77%. This contributed to the annual value of $47.3 million for FY2024, which is 4302.26% down from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Assets Average of $13.5 million as of Q3 2025, which was down 6901.77% from $20.5 million recorded in Q2 2025.
  • Over the past 5 years, Rani Therapeutics Holdings' Assets Average peaked at $130.6 million during Q4 2021, and registered a low of $13.5 million during Q3 2025.
  • Over the past 5 years, Rani Therapeutics Holdings' median Assets Average value was $77.0 million (recorded in 2023), while the average stood at $74.6 million.
  • As far as peak fluctuations go, Rani Therapeutics Holdings' Assets Average crashed by 80.88% in 2022, and later tumbled by 6901.77% in 2025.
  • Over the past 5 years, Rani Therapeutics Holdings' Assets Average (Quarter) stood at $130.6 million in 2021, then dropped by 17.21% to $108.1 million in 2022, then crashed by 40.64% to $64.2 million in 2023, then tumbled by 37.54% to $40.1 million in 2024, then crashed by 66.28% to $13.5 million in 2025.
  • Its Assets Average stands at $13.5 million for Q3 2025, versus $20.5 million for Q2 2025 and $30.4 million for Q1 2025.